Mediastinal lymph node dissection for the elderly with clinical stage I non-small cell lung cancer
Authors:
- 29 May 2021
- journal article
- research article
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 69 (12) , 1560-1566
Abstract
Objectives We aimed to compare the differences in prognosis and perioperative complications between patients with and without mediastinal lymph node dissection (MLND) among elderly patients with clinical stage I non-small cell lung cancer (NSCLC). Methods We analysed 439 patients ≥ 75 years of age with NSCLC classified as clinical stage I who underwent complete resection with lobectomy. We divided the patients into two groups. Those with MLND were included in the MLND group (n = 365), and those without MLND or adequate systematic mediastinal lymph node sampling were included in the non-MLND group (n = 74). To reduce selection bias, a propensity score matching method (3:1) was implemented. We compared survival and the incidence of perioperative complications. Results After matching, we compared 171 patients in the MLND group to 57 patients in the non-MLND group. There were no significant differences in clinicopathological characteristics between the groups. The non-MLND group did not show a significantly better prognosis than the MLND group in overall survival and cancer-specific survival (p = 0.246 and 0.150, respectively). The cumulative incidence of recurrence was similar in the two groups. MLND did not affect chest drain duration or hospitalization. The numbers of patients with perioperative complications ≥ grade 2 or ≥ grade 3 did not differ between the groups (p = 0.312 and > 0.999, respectively). Conclusions Anatomical pulmonary resection without MLND might be a treatment option for elderly patients with clinical stage I NSCLC. Further investigation is needed to clarify the value of MLND, especially for vulnerable elderly individuals.Keywords
This publication has 20 references indexed in Scilit:
- Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLCJournal of Thoracic Oncology, 2019
- Treatment strategy and decision-making for elderly surgical candidates with early lung cancerJournal of Thoracic Disease, 2019
- The influence of comorbidity on the postoperative survival in elderly (≥ 75 years old) with lung cancerGeneral Thoracic and Cardiovascular Surgery, 2018
- Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer in the Elderly: A Population-Based Study in Ontario, CanadaJournal of Clinical Oncology, 2012
- Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 TrialThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Pulmonary Resection in Patients Aged 80 Years or Over with Clinical Stage I Non-small Cell Lung Cancer: Prognostic Factors for Overall Survival and Risk Factors for Postoperative ComplicationsJournal of Thoracic Oncology, 2009
- ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer☆European Journal of Cardio-Thoracic Surgery, 2006
- Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2005
- Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancerThe Annals of Thoracic Surgery, 2000
- Radical lobectomyThe Journal of Thoracic and Cardiovascular Surgery, 1960